Retinol saturase in the mitochondria antagonizes IDH2 and GLUD1 acetylation to mediate heart repair.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41915751.
- Also identified by DOI 10.1073/pnas.2526203123 and PMC identifier 13056075.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Facilitating endogenous cardiomyocyte proliferation has emerged as an important strategy for cardiac repair. Conserved retinol saturase (Retsat) functions in producing all-trans 13,14-dihydroretinol in the endoplasmic reticulum (ER). However, Retsat's role and mechanism in heart regeneration remain unclear. Here, we uncover that Retsat is upregulated in cardiomyocytes during cardiac regeneration in mice. Cardiomyocyte-specific <i>Retsat</i> knockin promotes cardiac regeneration and improves cardiac function after injury. Conversely, cardiomyocyte-specific knockout of <i>Retsat</i> inhibits heart regeneration in neonatal mice. Surprisingly, Retsat drives cardiomyocyte proliferation independently of its classical retinol saturase activity in the ER. Retsat also localizes in cardiomyocyte mitochondria, and mitochondrial-specific overexpression of Retsat can stimulate cardiomyocyte proliferation and heart repair after injury. Mechanistically, Retsat in the mitochondria acts as an antagonist of Idh2 and Glud1 acetylation, reducing their acetylation levels and enhancing their activities. Furthermore, Retsat enters mitochondria by interacting with Tom70 and Tim23 proteins. These data suggest that targeting Retsat is a promising strategy for promoting cardiac regeneration after heart injury.
Medical subject headings
- Regeneration
- Isocitrate Dehydrogenase
- Mitochondria
- Heart
- Mitochondria, Heart